Stocktoria
Erasca, Inc. ERAS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-07-15
Erasca, Inc. statistics & valuation
Market cap$5.0B
P / B15.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -31.4% | -32.2% | -31.6% | -47.2% | -24.5% |
| Return on equity | -38.3% | -38.2% | -39.5% | -59.0% | -26.9% |
| Current ratio | 10.04 | 9.84 | 12.26 | 9.13 | 16.02 |
Source: SEC EDGAR filings · CIK 0001761918 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.